NCT00727428View on ClinicalTrials.gov

Immunogenicity and Safety of GSK Biologicals' FluLaval® TF

PHASE1CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 5, 2008

Primary Completion Date

August 29, 2008

Study Completion Date

February 17, 2009

Conditions
Influenza
Interventions
BIOLOGICAL

FluLaval® TF

One IM injection.

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY